Merit Medical Systems Revenue 2010-2023 | MMSI
Merit Medical Systems revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Merit Medical Systems Annual Revenue (Millions of US $) |
2023 |
$1,257 |
2022 |
$1,151 |
2021 |
$1,075 |
2020 |
$964 |
2019 |
$995 |
2018 |
$883 |
2017 |
$728 |
2016 |
$604 |
2015 |
$542 |
2014 |
$510 |
2013 |
$449 |
2012 |
$394 |
2011 |
$359 |
2010 |
$297 |
2009 |
$257 |
Merit Medical Systems Quarterly Revenue (Millions of US $) |
2023-12-31 |
$325 |
2023-09-30 |
$315 |
2023-06-30 |
$320 |
2023-03-31 |
$298 |
2022-12-31 |
$293 |
2022-09-30 |
$287 |
2022-06-30 |
$295 |
2022-03-31 |
$275 |
2021-12-31 |
$278 |
2021-09-30 |
$267 |
2021-06-30 |
$280 |
2021-03-31 |
$249 |
2020-12-31 |
$258 |
2020-09-30 |
$244 |
2020-06-30 |
$218 |
2020-03-31 |
$244 |
2019-12-31 |
$258 |
2019-09-30 |
$243 |
2019-06-30 |
$256 |
2019-03-31 |
$238 |
2018-12-31 |
$233 |
2018-09-30 |
$222 |
2018-06-30 |
$225 |
2018-03-31 |
$203 |
2017-12-31 |
$191 |
2017-09-30 |
$179 |
2017-06-30 |
$187 |
2017-03-31 |
$171 |
2016-12-31 |
$158 |
2016-09-30 |
$157 |
2016-06-30 |
$151 |
2016-03-31 |
$138 |
2015-12-31 |
$138 |
2015-09-30 |
$136 |
2015-06-30 |
$138 |
2015-03-31 |
$130 |
2014-12-31 |
$133 |
2014-09-30 |
$129 |
2014-06-30 |
$129 |
2014-03-31 |
$119 |
2013-12-31 |
$120 |
2013-09-30 |
$115 |
2013-06-30 |
$110 |
2013-03-31 |
$104 |
2012-12-31 |
$102 |
2012-09-30 |
$96 |
2012-06-30 |
$101 |
2012-03-31 |
$96 |
2011-12-31 |
$91 |
2011-09-30 |
$90 |
2011-06-30 |
$91 |
2011-03-31 |
$87 |
2010-12-31 |
$81 |
2010-09-30 |
$73 |
2010-06-30 |
$75 |
2010-03-31 |
$67 |
2009-12-31 |
$67 |
2009-09-30 |
$67 |
2009-06-30 |
$65 |
2009-03-31 |
$58 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical & Dental Supplies |
$4.182B |
$1.257B |
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
|